MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Tue Sep 10 00:00:00 GMT-05:00 2019
Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo’s DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Tue Sep 10 00:00:00 GMT-05:00 2019
Updated Phase 1 Data for Daiichi Sankyo’s U3-1402 in Patients with EGFR Mutated NSCLC Presented at 2019 World Conference on Lung Cancer
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Mon Sep 09 00:00:00 GMT-05:00 2019
Daiichi Sankyo Advances [Fam-] Trastuzumab Deruxtecan (DS-8201) in Japan with Regulatory Submission in HER2 Positive Metastatic Breast Cancer
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Wed Aug 21 00:00:00 GMT-05:00 2019
Updated Clinical Results and New Translational Research Data for Daiichi Sankyo’s ADCs U3-1402 and DS-1062 to be Presented at the 2019 World Conference on Lung Cancer
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Mon Aug 12 00:00:00 GMT-05:00 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Fri Aug 02 00:00:00 GMT-05:00 2019
FDA Approves Daiichi Sankyo’s TURALIO™ (pexidartinib) for the Treatment of Select Patients with TGCT, a Rare and Debilitating Tumor
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Fri Jun 21 00:00:00 GMT-05:00 2019
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Tue Jun 18 00:00:00 GMT-05:00 2019
Daiichi Sankyo’s VANFLYTA® Receives Approval in Japan for the Treatment of Relapsed/Refractory FLT3-ITD AML
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Sun Jun 02 00:00:00 GMT-05:00 2019
Daiichi Sankyo Presents Preliminary Phase 1 Data for TROP2 Targeting ADC DS-1062 in Patients with Non-Small Cell Lung Cancer at 2019 ASCO Annual Meeting
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)